Koyfin Home > Directory > Health Care > Albireo Pharma Inc > EBITDA Margin

Albireo Pharma Inc EBITDA Margin Chart (ALBO)

Albireo Pharma Inc annual/quarterly EBITDA Margin from 2015 to 2020. An EBITDA margin is a measurement of a company's earnings before interest, taxes, depreciation, and amortization as a percentage of its total revenue.
  • Albireo Pharma Inc EBITDA Margin for the quarter ending June 06, 2020 was $-951m a -56.43% increase of 536m year over year
  • Albireo Pharma Inc EBITDA Margin for the last 12 months ending June 06, 2020 was $-693m a -150.14% increase of 1,040m year over year
  • Albireo Pharma Inc Annual EBITDA Margin for 2019 was $-633m a 53.05% decrease of -336m from 2018
  • Albireo Pharma Inc Annual EBITDA Margin for 2018 was $-297m a -943,546.39% increase of 2,803,903m from 2017
  • Albireo Pharma Inc Annual EBITDA Margin for 2017 was $-2,804,200m a 100.00% decrease of -2,804,141m from 2016
Other Margins & Efficiency Metrics:
  • Albireo Pharma Inc Return on Capital % for the quarter ending September 09, 2018 was -22.13 a -46.96% increase of 10.39 year over year
  • Albireo Pharma Inc Return on Equity % for the quarter ending September 09, 2018 was -39.21 a 23.24% decrease of -9.11 year over year
View Chart On Koyfin

Quarterly ALBO EBITDA Margin Data

06/2020$-951m
03/2020$-1,905m
12/2019$-153m
09/2019$-1,487m
06/2019$-1,219m
03/2019$-2,691m
12/2018$-2,494m
09/2018$-5,339m
06/2018$-1,424m
03/2018$-5m

Annual ALBO EBITDA Margin Data

2019$-633m
2018$-297m
2017$-2,804,200m
2016$-59m
2015$-92m
2014$-262m